mmhodde

We are Axcend. We are leading a paradigm shift in analytical chemistry by offering robust, easy-to-use instruments that enable scientists to perform measurements anywhere—effectively “taking the lab to the sample.” We aim to communicate credibility, repeatability, and confidence to a target audience of conservative, change-resistant scientists. We are also exploring entirely new markets. Learn more by visiting our website: https://axcendcorp.com/

Catalyze acquires novel, market-ready technologies from Fortune 100 companies and transforms them into $100 million+ businesses. Led by a team of operators with a history of growing successful businesses, Catalyze leverages a unique commercialization model that prioritizes people, patience and performance. This approach enables us to position innovations where they can make the greatest impact, which gives our corporate partners a path to recouping investment dollars and our investors high-return potential in a lower-risk portfolio. Our audience is C-suite executives, corporate development leaders responsible for mergers and acquisitions, and research and development heads from Fortune 100 companies. A secondary audience is investors from family offices and venture capital firms who often are prior executives in business.

Designers please log in to view